Posted by Michael Wonder on 03 Dec 2023
Duchesnay is seeking Health Canada approval for a segesterone acetate/ethinyl estradiol contraceptive vaginal system, a new option for women
30 November 2023 - Duchesnay has recently filed a new drug submission to Health Canada for its segesterone acetate/ethinyl estradiol slow release vaginal system developed for contraception control.
With its long-acting properties, this product is another step toward bringing contraceptive choice, convenience and control to women around the world.
